Enhanced neutrophil activity is associated with shorter time to tumor progression in glioblastoma patients

OncoImmunology

Volumn 5, Issue 2, 2016, Pages

  Rahbar, Afsar ^a   Cederarv, Madeleine ^a   Wolmer Solberg, Nina ^a   Tammik, Charlotte ^a   Stragliotto, Giuseppe ^b   Peredo, Inti ^b   Fornara, Olesja ^a   Xu, Xinling ^a   Dzabic, Mensur ^a   Taher, Chato ^a   Skarman, Petra ^a   Söderberg Nauclér, Cecilia ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Cytokines; glioblastoma multiforme; human cytomegalovirus; neutrophils; time to tumor progression; valganciclovir

Indexed keywords

EID: 84959432767     PISSN: 21624011     EISSN: 2162402X     Source Type: Journal    
DOI: 10.1080/2162402X.2015.1075693     Document Type: Article

References (48)

1. T.Bergenheim, A.Malmstrom, H.Bolander, A.Michanek, G.Stragliotto, L.Damber, O.Björ, R.Henriksson. Registration on regional basis of patients with primary brain tumors. Regional differences disclosed. Lakartidningen 2007; 104:332-8, 340–1; PMID:17328357
2. R.Stupp, W.P.Mason, M.J.van den Bent, M.Weller, B.Fisher, M.J.B.Taphoorn, K.Belanger, A.A.Brandes, C.Marosi, U.Bogdahn et al. Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma. N Engl J Med 2005; 352:987-96; PMID:15758009; http://dx.doi.org/10.1056/NEJMoa043330
3. M.G.Hart, R.Grant, R.Garside, G.Rogers, M.Somerville, K.Stein. Temozolomide for high grade glioma. Cochrane Database Syst Rev 2008; 8(4): CD007415; PMID:18843749; http://dx.doi.org/10.1002/14651858.CD007415
4. M.L.Affronti, C.R.Heery, J.E.Herndon, 2nd, J.N.Rich, D.A.Reardon, A.Desjardins, J.J.Vredenburgh, A.H.Friedman, D.D.Bigner, H.S.Friedman. Overall survival of newly diagnosed glioblastoma patients receiving carmustine wafers followed by radiation and concurrent temozolomide plus rotational multiagent chemotherapy. Cancer 2009; 115:3501-11; PMID:19514083; http://dx.doi.org/10.1002/cncr.24398
5. M.Weller, A.Fontana. The failure of current immunotherapy for malignant glioma. Tumor-derived TGF-beta, T-cell apoptosis, and the immune privilege of the brain. Brain Res Brain Res Rev 1995; 21:128-51; PMID:8866671; http://dx.doi.org/10.1016/0165-0173(95)00010-0
6. A.Waziri. Glioblastoma-derived mechanisms of systemic immunosuppression. Neurosurg Clin North Am 2010; 21:31-42; http://dx.doi.org/10.1016/j.nec.2009.08.005
7. Y.C.Ooi, P.Tran, N.Ung, K.Thill, A.Trang, B.M.Fong, D.T.Nagasawa, M.Lim, I.Yang. The role of regulatory T-cells in glioma immunology. Clin Neurol Neurosurg 2014; 119:125-32; PMID:24582432; http://dx.doi.org/10.1016/j.clineuro.2013.12.004
8. B.Kaminska, M.Kocyk, M.Kijewska. TGF beta signaling and its role in glioma pathogenesis. Adv Exp Med Biol 2013; 986:171-87; PMID:22879069; http://dx.doi.org/10.1007/978-94-007-4719-7_9
9. G.Fossati, G.Ricevuti, S.W.Edwards, C.Walker, A.Dalton, M.L.Rossi. Neutrophil infiltration into human gliomas. Acta Neuropathol 1999; 98:349-54; PMID:10502039; http://dx.doi.org/10.1007/s004010051093
10. K.Iwatsuki, E.Kumara, T.Yoshimine, H.Nakagawa, M.Sato, T.Hayakawa. Elastase expression by infiltrating neutrophils in gliomas. Neurol Res 2000; 22:465-8; PMID:10935217
11. W.S.Hor, W.L.Huang, Y.S.Lin, B.C.Yang. Cross-talk between tumor cells and neutrophils through the Fas (APO-1, CD95)/FasL system: human glioma cells enhance cell viability and stimulate cytokine production in neutrophils. J Leukoc Biol 2003; 73:363-8; PMID:12629150; http://dx.doi.org/10.1189/jlb.0702375
12. C.Soderberg-Naucler. HCMV microinfections in inflammatory diseases and cancer. J Clin Virol 2008; 41:218-23; PMID:18164235; http://dx.doi.org/10.1016/j.jcv.2007.11.009
13. K.Straat, C.Liu, A.Rahbar, Q.Zhu, L.Liu, N.Wolmer-Solberg, F.Lou, Z.Liu, J.Shen, J.Jia et al. Activation of telomerase by human cytomegalovirus. J Natl Cancer Inst 2009; 101:488-97; PMID:19318640; http://dx.doi.org/10.1093/jnci/djp031
14. A.Rahbar, A.Orrego, I.Peredo, M.Dzabic, N.Wolmer-Solberg, K.Straat, G.Stragliotto, C.Söderberg-Nauclér. Human cytomegalovirus infection levels in glioblastoma multiforme are of prognostic value for survival. J Clin Virol 2013; 57:36-42; PMID:23391370; http://dx.doi.org/10.1016/j.jcv.2012.12.018
15. C.S.Cobbs, L.Harkins, M.Samanta, G.Y.Gillespie, S.Bharara, P.H.King, L.B.Nabors, C.G.Cobbs, W.J.Britt. Human cytomegalovirus infection and expression in human malignant glioma. Cancer Res 2002; 62:3347-50; PMID:12067971
16. K.G.Lucas, L.Bao, R.Bruggeman, K.Dunham, C.Specht. The detection of CMV pp65 and IE1 in glioblastoma multiforme. J Neuro-oncol 2011; 103:231-8; http://dx.doi.org/10.1007/s11060-010-0383-6; PMID:20820869
17. N.Baryawno, A.Rahbar, N.Wolmer-Solberg, C.Taher, J.Odeberg, A.Darabi, Z.Khan, B.Sveinbjörnsson, O.M.FuskevÅg, L.Segerström et al. Detection of human cytomegalovirus in medulloblastomas reveals a potential therapeutic target. J Clin Invest 2011; 121:4043-55; PMID:21946257; http://dx.doi.org/10.1172/JCI57147
18. N.Wolmer-Solberg, N.Baryawno, A.Rahbar, D.Fuchs, J.Odeberg, C.Taher, V.Wilhelmi, J.Milosevic, A.A.Mohammad, T.Martinsson et al. Frequent detection of human cytomegalovirus in neuroblastoma: a novel therapeutic target? Int J Cancer 2013; 133:2351-61; PMID:23661597; http://dx.doi.org/10.1189/jlb.0702375
19. L.Harkins, A.L.Volk, M.Samanta, I.Mikolaenko, W.J.Britt, K.I.Bland, C.S.Cobbs. Specific localisation of human cytomegalovirus nucleic acids and proteins in human colorectal cancer. Lancet 2002; 360:1557-63; PMID:12443594; http://dx.doi.org/10.1016/S0140-6736(02)11524-8
20. C.Taher, J.de Boniface, A.A.Mohammad, P.Religa, J.Hartman, K.C.Yaiw, J.Frisell, A.Rahbar, C.Söderberg-Naucler. High prevalence of human cytomegalovirus proteins and nucleic acids in primary breast cancer and metastatic sentinel lymph nodes. PloS One 2013; 8:e56795; PMID:23451089; http://dx.doi.org/10.1371/journal.pone.0056795
21. C.Taher, G.Frisk, S.Fuentes, P.Religa, H.Costa, A.Assinger, K.K.Vetvik, I.R.Bukholm, K.C.Yaiw, K.E.Smedby et al. High prevalence of human cytomegalovirus in brain metastases of patients with primary breast and colorectal cancers. Transl Ooncol 2014; 7:732-40; PMID: 25500083; http://dx.doi.org/10.1016/j.tranon.2014.09.008
22. L.E.Harkins, L.A.Matlaf, L.Soroceanu, K.Klemm, W.J.Britt, W.Wang, K.I.Bland, C.S.Cobbs. Detection of human cytomegalovirus in normal and neoplastic breast epithelium. Herpesviridae 2010; 1:8; PMID:21429243; http://dx.doi.org/10.1186/2042-4280-1-8
23. M.El-Shinawi, H.T.Mohamed, E.A.El-Ghonaimy, M.Tantawy, A.Younis, R.J.Schneider, M.M.Mohamed. Human cytomegalovirus infection enhances NF-kappaB/p65 signaling in inflammatory breast cancer patients. PloS One 2013; 8:e55755; PMID:23418456; http://dx.doi.org/10.1371/journal.pone.0055755
24. M.Samanta, L.Harkins, K.Klemm, W.J.Britt, C.S.Cobbs. High prevalence of human cytomegalovirus in prostatic intraepithelial neoplasia and prostatic carcinoma. J Urol 2003; 170:998-1002; PMID:12913758; http://dx.doi.org/10.1097/01.ju.0000080263.46164.97
25. B.A.Forbes. Acquisition of cytomegalovirus infection: an update. Clin Microviol Rev 1989; 2:204-16
26. I.Boldogh, S.AbuBakar, C.Z.Deng, T.Albrecht. Transcriptional activation of cellular oncogenes fos, jun, and myc by human cytomegalovirus. J Virol 1991; 65:1568-71; PMID:1847472
27. I.Boldogh, S.AbuBakar, M.P.Fons, C.Z.Deng, T.Albrecht. Activation of cellular oncogenes by clinical isolates and laboratory strains of human cytomegalovirus. J Med Virol 1991; 34:241-7; PMID:1719130; http://dx.doi.org/10.1002/jmv.1890340409
28. J.CinatlJr, J.U.Vogel, R.Kotchetkov, H.Wilhelm Doerr. Oncomodulatory signals by regulatory proteins encoded by human cytomegalovirus: a novel role for viral infection in tumor progression. FEMS Microbiol Rev 2004; 28:59-77; PMID:14975530; http://dx.doi.org/10.1016/j.femsre.2003.07.005
29. L.Graf, R.Webel, S.Wagner, S.T.Hamilton, W.D.Rawlinson, H.Sticht, M.Marschall. The cyclin-dependent kinase ortholog pUL97 of human cytomegalovirus interacts with cyclins. Viruses 2013; 5:3213-30; PMID:24351800; http://dx.doi.org/10.3390/v5123213
30. A.Skaletskaya, L.M.Bartle, T.Chittenden, A.L.McCormick, E.S.Mocarski, V.S.Goldmacher. A cytomegalovirus-encoded inhibitor of apoptosis that suppresses caspase-8 activation. Proc Natl Acad Sci USA 2001; 98:7829-34; PMID:11427719; http://dx.doi.org/10.1073/pnas.141108798
31. G.Stragliotto, A.Rahbar, N.W.Solberg, A.Lilja, C.Taher, A.Orrego, B.Bjurman, C.Tammik, P.Skarman, I.Peredo et al. Effects of valganciclovir as an add-on therapy in patients with cytomegalovirus-positive glioblastoma: a randomized, double-blind, hypothesis-generating study. Int J Cancer 2013; 133:1204-13; PMID:23404447; http://dx.doi.org/10.1002/ijc.28111
32. C.Soderberg-Naucler, A.Rahbar, G.Stragliotto, C.Soderberg-Naucler. Survival in patients with glioblastoma receiving valganciclovir. N Engl J Med 2013; 369:985-86; PMID:24004141; http://dx.doi.org/10.1056/NEJMc1302145
33. P.J.Skarman, A.Rahbar, X.Xie, C.Soderberg-Naucler. Induction of polymorphonuclear leukocyte response by human cytomegalovirus. Microbes Infect 2006; 8:1592-601; PMID:16702012; http://dx.doi.org/10.1016/j.micinf.2006.01.017
34. Q.Zheng, R.Tao, H.Gao, J.Xu, S.Shang, N.Zhao. HCMV-encoded UL128 enhances TNF-alpha and IL-6 expression and promotes PBMC proliferation through the MAPK/ERK pathway in vitro. Viral Immunol 2012; 25:98-105; PMID:22486303; http://dx.doi.org/10.1089/vim.2011.0064
35. A.Rahbar, I.Peredo, N.W.Solberg, C.Taher, M.Dzabic, X.Xu, P.Skarman, O.Fornara, C.Tammik, K.Yaiw et al. Discordant humoral and cellular immune responses to Cytomegalovirus (CMV) in glioblastoma patients whose tumors are positive for CMV. OncoImmunology 2014; 4: e982391-1-e982391-8; PMID: 25949880; http://dx.doi.org/10.4161/2162402X.2014.982391
36. S.H.Ferreira, S.E.Moreno, J.C.Alves-Filho, T.M.Alfaya, J.S.Da Silva, F.Y.Liew. IL-12, but not IL-18, is critical to neutrophil activation and resistance to polymicrobial sepsis induced by cecal ligation and puncture. J Immunol 2006; 177:3218-24; PMID:16920961; http://dx.doi.org/10.4049/jimmunol.177.5.3218
37. G.Eisele, J.Wischhusen, M.Mittelbronn, R.Meyermann, I.Waldhauer, A.Steinle, M.Weller, M.A.Friese. TGF-beta and metalloproteinases differentially suppress NKG2D ligand surface expression on malignant glioma cells. Brain 2006; 129:2416-25; PMID:16891318; http://dx.doi.org/10.1093/brain/awl205
38. J.Wischhusen, M.A.Friese, M.Mittelbronn, R.Meyermann, M.Weller. HLA-E protects glioma cells from NKG2D-mediated immune responses in vitro: implications for immune escape in vivo. J Neuropathol Exp Neurol 2005; 64:523-8; PMID:15977644
39. T.Roszman, L.Elliott, W.Brooks. Modulation of T-cell function by gliomas. Immunol Today 1991; 12:370-4; PMID:1958290; http://dx.doi.org/10.1016/0167-5699(91)90068-5
40. M.Rapp, Z.Ozcan, H.J.Steiger, P.Wernet, M.C.Sabel, R.V.Sorg. Cellular immunity of patients with malignant glioma: prerequisites for dendritic cell vaccination immunotherapy. J Neuerosurg 2006; 105:41-50; PMID: 16874889; http://dx.doi.org/10.3171/jns.2006.105.1.41
41. C.A.Fielding, R.M.McLoughlin, L.McLeod, C.S.Colmont, M.Najdovska, D.Grail, M.Ernst, S.A.Jones, N.Topley, B.J.Jenkins. IL-6 regulates neutrophil trafficking during acute inflammation via STAT3. J Immunol 2008; 181:2189-95; PMID:18641358; http://dx.doi.org/10.4049/jimmunol.181.3.2189
42. M.E.Hammond, G.R.Lapointe, P.H.Feucht, S.Hilt, C.A.Gallegos, C.A.Gordon, M.A.Giedlin, G.Mullenbach, P.Tekamp-Olson. IL-8 induces neutrophil chemotaxis predominantly via type I IL-8 receptors. J Immunol 1995; 155:1428-33; PMID:7636208
43. M.K.Gately, L.M.Renzetti, J.Magram, A.S.Stern, L.Adorini, U.Gubler, D.H.Presky. The interleukin-12/interleukin-12-receptor system: role in normal and pathologic immune responses. Annu Rev Immunol 1998; 16:495-521; PMID:9597139; http://dx.doi.org/10.1146/annurev.immunol.16.1.495
44. E.Y.Denkers, L.Del Rio, S.Bennouna. Neutrophil production of IL-12 and other cytokines during microbial infection. Chem Immunol Allergy 2003; 83:95-114; PMID:12947981; http://dx.doi.org/10.1159/000071557
45. M.Daheshia, S.Kanangat, B.T.Rouse. Production of key molecules by ocular neutrophils early after herpetic infection of the cornea. Exp Eye Res 1998; 67:619-24; PMID:9990326; http://dx.doi.org/10.1006/exer.1998.0565
46. S.Kanangat, J.Thomas, S.Gangappa, J.S.Babu, B.T.Rouse. Herpes simplex virus type-1 mediated up-regulation of IL-12 (p40) mRNA expression. Implications in immnuopathogenesis and protection. J Immunol 1996; 156:1110-6; PMID:8557986
47. K.1.Iwatsuki, E.Kumara, T.Yoshimine, H.Nakagawa, M.Sato, T.Hayakawa. Elastase expression by infiltrating neutrophils in gliomas. Neurol Res. 2000; 22:465-8
48. A.Boyum. Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g. Scand J Clin Lab Invest Suppl 1968; 97:77-89; PMID:4179068